MedPath

Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer

Not Applicable
Active, not recruiting
Conditions
Stage III Pancreatic Cancer
Pancreatic Adenocarcinoma Non-resectable
Interventions
Other: Dietary Intervention
Other: Best Practice
Other: Medical Chart Review
Other: Medical Device Usage and Evaluation
Other: Nutritional Assessment
Other: Questionnaire Administration
Registration Number
NCT06090916
Lead Sponsor
Jonsson Comprehensive Cancer Center
Brief Summary

This clinical trial compares the effect of malnutrition screening and dietary intervention to standard nutrition care on patients with pancreatic cancer that cannot be removed by surgery (unresectable). Fewer than 20% of patients diagnosed with unresectable pancreatic cancer do not survive one year after diagnosis so treatment often focuses on improving quality of life. Many patients experience increasing pain, nausea, vomiting, loss of appetite, weight loss and weakness. Behavioral interventions use techniques to help patients change the way they react to environmental triggers that may cause a negative reaction. Screening for inadequate nutrition (malnutrition) and providing weekly nutritional support may be effective methods to improve nutritional status and improve overall quality of life for patients with unresectable pancreatic cancer.

Detailed Description

PRIMARY OBJECTIVES:

I. To compare the quality of life of subjects after 12 weeks between the intervention group with nutrition optimization with dietary prescription and nutrition support in comparison to standard care.

II. To compare the frequency of hospitalization and length of stay (LOS) after 12 weeks between the intervention group with nutrition optimization with dietary prescription and nutrition support in comparison to standard care.

III. To compare the subject's functional status, body weight and dietary intake after 12 weeks between the intervention group with nutrition optimization with dietary prescription and nutrition support in comparison to standard care.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive standard nutrition care and record dietary intake and physical activity using Myfitness Pal smartphone application on study.

ARM II: Patients undergo malnutrition screening with a registered dietician at baseline and participate in 12 weekly nutrition support sessions and those at moderate to high risk for malnutrition receive a personalized diet prescription on study. Patients also record dietary intake and physical activity using Myfitness Pal smartphone application on study.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Unresectable pancreatic adenocarcinoma, receiving either 1) no chemotherapy, 2) 1st cycle of chemotherapy, or 3) greater than 1 cycle of chemotherapy if the patient's prognosis is greater than 6 months as determined by oncology collaborators
  • Life expectancy of greater than 3 months and a Karnofsky performance score of 60 or more
  • Adults >= 18 years old male or female
Exclusion Criteria
  • Ascites requiring paracentesis for symptom improvement
  • Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) values greater than 5 times the upper limit of normal
  • Creatinine value greater than 2.0 for men and 1.5 for women
  • Uncontrolled pain
  • Uncontrolled nausea and vomiting

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ARM II (Dietary intervention)Medical Device Usage and EvaluationPatients undergo malnutrition screening with a registered dietician at baseline and participate in 12 weekly nutrition support sessions and those at moderate to high risk for malnutrition receive a personalized diet prescription on study. Patients also record dietary intake and physical activity using Myfitness Pal smartphone application on study.
ARM II (Dietary intervention)Questionnaire AdministrationPatients undergo malnutrition screening with a registered dietician at baseline and participate in 12 weekly nutrition support sessions and those at moderate to high risk for malnutrition receive a personalized diet prescription on study. Patients also record dietary intake and physical activity using Myfitness Pal smartphone application on study.
ARM II (Dietary intervention)Dietary InterventionPatients undergo malnutrition screening with a registered dietician at baseline and participate in 12 weekly nutrition support sessions and those at moderate to high risk for malnutrition receive a personalized diet prescription on study. Patients also record dietary intake and physical activity using Myfitness Pal smartphone application on study.
ARM I (Standard of care)Medical Device Usage and EvaluationPatients receive standard nutrition care and record dietary intake and physical activity using Myfitness Pal smartphone application on study.
ARM II (Dietary intervention)Medical Chart ReviewPatients undergo malnutrition screening with a registered dietician at baseline and participate in 12 weekly nutrition support sessions and those at moderate to high risk for malnutrition receive a personalized diet prescription on study. Patients also record dietary intake and physical activity using Myfitness Pal smartphone application on study.
ARM I (Standard of care)Best PracticePatients receive standard nutrition care and record dietary intake and physical activity using Myfitness Pal smartphone application on study.
ARM I (Standard of care)Medical Chart ReviewPatients receive standard nutrition care and record dietary intake and physical activity using Myfitness Pal smartphone application on study.
ARM I (Standard of care)Questionnaire AdministrationPatients receive standard nutrition care and record dietary intake and physical activity using Myfitness Pal smartphone application on study.
ARM II (Dietary intervention)Nutritional AssessmentPatients undergo malnutrition screening with a registered dietician at baseline and participate in 12 weekly nutrition support sessions and those at moderate to high risk for malnutrition receive a personalized diet prescription on study. Patients also record dietary intake and physical activity using Myfitness Pal smartphone application on study.
Primary Outcome Measures
NameTimeMethod
Quality of life measured comparing changes in outcomes between study armsAfter 12 weeks

Measured using short form 36. A two-sample t-test comparing changes from baseline in each of the outcomes between study arms used to estimate power

Frequency of hospitalizationsAfter 12 weeks

Hospitalization defined as any stay in the hospital \> 24 hours. A two-sample t-test comparing changes from baseline in each of the outcomes between study arms used to estimate power

Length of hospital stayAfter 12 weeks

Length of stay determined by the number of days of hospitalization including the date of admission and not including the day of discharge from the hospital. A two-sample t-test comparing changes from baseline in each of the outcomes between study arms used to estimate power

Functional status using Karnofsky performance scoreAfter 12 weeks

The Karnofsky Performance Status (KPS) is a standardized measure used to assess a patient's ability to perform everyday tasks. It ranges from 0 to 100, with higher scores indicating better function.

Average daily stepsAfter 12 weeks

Daily steps recorded using MyfitnessPal. A two-sample t-test comparing changes from baseline in each of the outcomes between study arms used to estimate power

Percent change in body weightBaseline to after 12 weeks

Collected from patient medical record. A two-sample t-test comparing changes from baseline in each of the outcomes between study arms used to estimate power

Calorie intake from Myfitness PalAfter 12 weeks

Food intake collected every 4 weeks and uploaded into patients medical record via patient portal. A two-sample t-test comparing changes from baseline in each of the outcomes between study arms used to estimate power

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UCLA / Jonsson Comprehensive Cancer Center

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath